摘要 |
This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. |
申请人 |
ABBOTT LABORATORIES;ABBOTT GMBH & CO.KG;MARING, CLARENCE J.;PRATT, JOHN K.;CARROLL, WILLIAM A.;LIU, DACHUN;BETEBENNER, DAVID A.;HUTCHINSON, DOUGLAS K.;TUFANO, MICHAEL D.;ROCKWAY, TODD W.;SCHOEN, UWE;PAHL, AXEL;WITTE, ADREAS |
发明人 |
MARING, CLARENCE J.;PRATT, JOHN K.;CARROLL, WILLIAM A.;LIU, DACHUN;BETEBENNER, DAVID A.;HUTCHINSON, DOUGLAS K.;TUFANO, MICHAEL D.;ROCKWAY, TODD W.;SCHOEN, UWE;PAHL, AXEL;WITTE, ADREAS |